Crescent Capital BDC, Inc. (NASDAQ:CCAP) Short Interest Down 30.8% in September

Crescent Capital BDC, Inc. (NASDAQ:CCAP) saw a significant decline in short interest in September. As of September 15th, there was short interest totalling 87,500 shares, a decline of 30.8% from the August 31st total of 126,500 shares. Based on an average trading volume of 138,500 shares, the short-interest ratio is currently 0.6 days.

Institutional Trading of Crescent Capital BDC

A number of institutional investors have recently bought and sold shares of CCAP. Point72 Asset Management L.P. purchased a new stake in shares of Crescent Capital BDC in the 2nd quarter valued at $90,000. Tucker Asset Management LLC purchased a new position in shares of Crescent Capital BDC during the 4th quarter valued at approximately $167,000. XTX Topco Ltd acquired a new position in shares of Crescent Capital BDC in the 2nd quarter valued at $195,000. Alpine Global Management LLC purchased a new position in Crescent Capital BDC in the first quarter valued at $217,000. Finally, Catalina Capital Group LLC purchased a new position in shares of Crescent Capital BDC in the 2nd quarter valued at about $220,000. 49.46% of the stock is currently owned by institutional investors and hedge funds.

Crescent Capital BDC Price Performance

NASDAQ CCAP traded up $0.06 during trading on Friday, hitting $18.84. 111,018 shares of the stock traded hands, compared to its average volume of 136,709. The company has a market capitalization of $698.25 million, a P/E ratio of 6.70 and a beta of 0.81. Crescent Capital BDC has a 12-month low of $15.03 and a 12-month high of $19.63. The firm has a 50-day simple moving average of $18.38 and a 200-day simple moving average of $18.15. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.01. The firm had revenue of $48.95 million during the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. During the same quarter in the previous year, the business earned $0.56 earnings per share. As a group, analysts predict that Crescent Capital BDC will post 2.34 EPS for the current year.

Crescent Capital BDC Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th will be given a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 8.92%. The ex-dividend date is Monday, September 30th. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.09. Crescent Capital BDC’s dividend payout ratio is presently 59.79%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on CCAP shares. Bank of America reduced their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Thursday, August 15th. Wells Fargo & Company reduced their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 14th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $18.80.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.